Literature DB >> 25852211

Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.

Cuneyt Kocas1, Ahmet Yildiz2, Okay Abaci1, Osman Sukru Karaca1, Nur Firdin1, Yalcin Dalgic1, Cem Bostan1, Murat Ersanli1.   

Abstract

We assessed the relation between platelet-to-lymphocyte ratio (PLR) on admission and contrast-induced nephropathy (CIN) in patients with non-ST-segment elevation acute coronary syndrome (NSTE-ACS). A total of 488 patients with NSTE-ACS who underwent urgent coronary angiography were enrolled. Levels of PLR and creatinine were measured before angiography and at 72 hours after angiography. Patients were divided into 2 groups, namely, the CIN group, 80 patients (16.3%; age 65.3 ± 12.5years; 66.7% men) and the non-CIN group, 408 patients (83.7%; age 61.2 ± 12.3 years; 72.5% men). Patients in the CIN group had significantly higher PLR than those in the non-CIN group (152.9 ± 99.6 vs 120.4 ± 66.1, P < .001). In logistic regression analysis, PLR (odds ratio [OR] 1.004, 95% confidence interval [CI] 1.001-1.007, P = .02), diabetes mellitus (OR 1.75, 95% CI 1.02-2.98, P = .03), and ST-segment depression on admission electrocardiogram (OR 1.68, 95% CI 1.00-2.81, P = .04) were independent predictors of CIN. The PLR was an independent predictor of CIN after angiography in patients with NSTE-ACS.
© The Author(s) 2015.

Entities:  

Keywords:  acute coronary syndrome; contrast-induced nephropathy; platelet-to-lymphocyte ratio

Mesh:

Substances:

Year:  2015        PMID: 25852211     DOI: 10.1177/0003319715578057

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  7 in total

1.  Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome.

Authors:  Irem Karauzum; Kurtulus Karauzum; Burak Acar; Kaan Hanci; Halil Ibrahim Ulas Bildirici; Teoman Kilic; Ertan Ural
Journal:  J Transl Int Med       Date:  2021-07-09

2.  Development and Validation of a Risk Nomogram Model for Predicting Contrast-Induced Acute Kidney Injury in Patients with Non-ST-Elevation Acute Coronary Syndrome Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Kai Ma; Jing Li; Guoqi Shen; Di Zheng; Yongli Xuan; Yuan Lu; Wenhua Li
Journal:  Clin Interv Aging       Date:  2022-01-26       Impact factor: 4.458

3.  Could platelet-to-lymphocyte ratio be a predictor for contrast-induced nephropathy in patients with acute coronary syndrome?: A systematic review and meta-analysis.

Authors:  Jie Jiang; Hong-Yan Ji; Wei-Ming Xie; Lu-Sen Ran; Yu-Si Chen; Cun-Tai Zhang; Xiao-Qing Quan
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  The prognostic role of platelet-to-lymphocyte ratio in patients with acute heart failure: A cohort study.

Authors:  Gui-Lian Ye; Qiang Chen; Xueyu Chen; Ying-Ying Liu; Ting-Ting Yin; Qing-He Meng; Ying-Chao Liu; Huai-Qing Wei; Qing-Hua Zhou
Journal:  Sci Rep       Date:  2019-07-23       Impact factor: 4.379

5.  Correlation of the Neutrophil-to-Lymphocyte Ratio (NLR) and Platelet-to-Lymphocyte Ratio (PLR) with Contrast-Induced Nephropathy in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Interventions.

Authors:  Khurram Butt; Jason D'Souza; Cai Yuan; Jayapriya Jayakumaran; Michelle Nguyen; Hamza I Butt; Khalid Abusaada
Journal:  Cureus       Date:  2020-12-03

6.  Association between Serum Ferritin and Contrast-Induced Nephropathy in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Authors:  Boqian Zhu; Jiantong Hou; Yaoyao Gong; Gaoliang Yan; Qingjie Wang; Dong Wang; Yong Qiao; Yifei Chen; Chengchun Tang
Journal:  Biomed Res Int       Date:  2016-07-28       Impact factor: 3.411

7.  Fibrinogen-to-Albumin Ratio Predicts Contrast-Induced Nephropathy in Patients after Emergency Percutaneous Coronary Intervention.

Authors:  Zhebin You; Tailin Guo; Fan Lin; Chunjin Lin; Jiankang Chen; Xiaoming Li; Yan Chen; Kaiyang Lin
Journal:  Cardiol Res Pract       Date:  2019-11-11       Impact factor: 1.866

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.